These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 29025423)

  • 1. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
    Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
    Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
    Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
    Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ku80 cooperates with CBP to promote COX-2 expression and tumor growth.
    Xiao Y; Wang J; Qin Y; Xuan Y; Jia Y; Hu W; Yu W; Dai M; Li Z; Yi C; Zhao S; Li M; Du S; Cheng W; Xiao X; Chen Y; Wu T; Meng S; Yuan Y; Liu Q; Huang W; Guo W; Wang S; Deng W
    Oncotarget; 2015 Apr; 6(10):8046-61. PubMed ID: 25797267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
    Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
    Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
    Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
    Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
    Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
    Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
    Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
    Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
    Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.
    Xuan Y; Wang J; Ban L; Lu JJ; Yi C; Li Z; Yu W; Li M; Xu T; Yang W; Tang Z; Tang R; Xiao X; Meng S; Chen Y; Liu Q; Huang W; Guo W; Cui X; Deng W
    Mol Oncol; 2016 Apr; 10(4):610-24. PubMed ID: 26774881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
    Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
    J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
    Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
    Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
    Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
    J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
    Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB.
    Li D; Sun J; Liu W; Wang X; Bals R; Wu J; Quan W; Yao Y; Zhang Y; Zhou H; Wu K
    Oncotarget; 2016 Oct; 7(40):66032-66050. PubMed ID: 27602766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
    Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
    J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.